OAsIs trial update: ibrutinib, venetoclax plus obinutuzumab in newly diagnosed MCL
Simon Rule • 7 Dec 2019
Safety profiles of idelalisib, duvelisib and TGR-1202 in treating CLL
Jennifer Brown • 10 Aug 2017
Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.